MEDOVEX CORP (MDVX) financial statements (2021 and earlier)

Company profile

Business Address 201 E KENNEDY BLVD STE 700
TAMPA, FL 33602
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3683002,59247228114126
Cash and cash equivalents3683002,59247228114126
Receivables7180158146151189270
Inventory, net of allowances, customer advances and progress billings126129129131206294306
Inventory126129129131206294306
Prepaid expense1992953654659111140
Total current assets:7648043,244371644708843
Noncurrent Assets
Operating lease, right-of-use asset8599731,092
Property, plant and equipment23525927530677380
Intangible assets, net (including goodwill)15,69214,6618,630    
Goodwill12,56411,3495,134    
Intangible assets, net (excluding goodwill)3,1283,3123,496    
Deposits noncurrent assets   3333
Other noncurrent assets292941    
Total noncurrent assets:16,81615,92310,03733697683
TOTAL ASSETS:17,58016,72613,282404714784926
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,6791,3871,5841,5751,157763672
Accounts payable1,953717941751689493511
Accrued liabilities54342227321124319090
Employee-related liabilities  170451125  
Interest and dividends payable1842471991621008071
Deferred revenue1,365838396
Debt1,3281,3021,294697587188387
Due to related parties1,250  91703513
Other liabilities532733228    
Other undisclosed current liabilities114  37   
Total current liabilities:7,2684,2603,5012,4001,8149861,072
Noncurrent Liabilities
Long-term debt and lease obligation419512630  622
Long-term debt, excluding current maturities23    622
Operating lease, liability396512630
Other undisclosed noncurrent liabilities332  0000
Total noncurrent liabilities:75151263000623
Other undisclosed liabilities     (0) 
Total liabilities:8,0204,7724,1312,4011,8149921,095
Stockholders' equity
Stockholders' equity attributable to parent, including:9,56111,9549,151(1,997)(1,101)(207)(169)
Common stock99999425242323
Additional paid in capital25,81925,70617,61135,81235,20534,92733,879
Accumulated deficit(15,988)(13,481)(8,183)(37,834)(36,329)(35,157)(34,071)
Other undisclosed stockholders' equity attributable to parent(370)(370)(370)000 
Other undisclosed stockholders' equity     0 
Total stockholders' equity:9,56111,9549,151(1,997)(1,101)(207)(169)
TOTAL LIABILITIES AND EQUITY:17,58016,72613,282404714784926

Income statement (P&L) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues2,7422,4321,324213209252144
Cost of revenue(550)(492)(559)(77)(122)(205)(98)
Cost of goods and services sold(550)(492)    (98)
Other undisclosed gross profit   6(3)(3)(1)
Gross profit:2,1921,940765142844545
Operating expenses(5,619)(7,159)(4,367)(1,446)(1,212)(1,092)(1,293)
Operating loss:(3,427)(5,219)(3,602)(1,304)(1,128)(1,047)(1,248)
Nonoperating income (expense)803(78)92(6)456
Foreign currency transaction gain, before tax 9  450
Interest and debt expense(80)(87)(92)(89)(40)(27)(1)
Net loss:(2,704)(5,384)(3,602)(1,398)(1,164)(1,069)(1,243)
Other undisclosed net income (loss) attributable to parent8087(93)2(8)(17)(11)
Net loss attributable to parent:(2,624)(5,297)(3,695)(1,397)(1,172)(1,086)(1,254)
Preferred stock dividends and other adjustments(21)(21)(25)(39)(12)(8) 
Other undisclosed net loss available to common stockholders, basic  (437)(252) (259) 
Net loss available to common stockholders, diluted:(2,645)(5,318)(4,156)(1,687)(1,184)(1,353)(1,254)

Comprehensive Income ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net loss:(2,704)(5,384)(3,602)(1,398)(1,164)(1,069)(1,243)
Comprehensive loss, net of tax, attributable to parent:(2,704)(5,384)(3,602)(1,398)(1,164)(1,069)(1,243)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: